Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Microba Ip Pty Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is handled by a single distinct examiner and 1 distinct art unit. The concentration of the company's current prosecution activity in a single art unit and under one examiner indicates a very focused technical application within the biotechnology sector. This alignment suggests that the company is pursuing a specific biological innovation that falls under a specialized examination group.
WEIHUA FAN is the busiest examiner for the company, with the pending office action. This action is the only pending matter for the portfolio. Because the company has only one action pending, the prosecution strategy is entirely dependent on the interactions with this specific examiner. This lack of volume across multiple examiners means the company's current office presence is minimal and highly centralized, focusing all immediate efforts on a single point of review and a specific set of examiner expectations within the biotechnology field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FAN, WEIHUA | 1 | 83.4% | +12.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18709255 | BACTERIAL STRAINS FOR TREATING DISEASE | FAN, WEIHUA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18709255 | BACTERIAL STRAINS FOR TREATING DISEASE | FAN, WEIHUA | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18709255 | BACTERIAL STRAINS FOR TREATING DISEASE | FAN, WEIHUA | 1663 | §112 | Final Rejection | — | Pending | May 10, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial